PCMA Policy Platform Prioritizes Patients with Solutions to Promote Competition, Lower Drug Costs, Support Better Health Outcomes & Maximize the Value of Pharmacy Benefits (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released today a new policy platform, “Unlocking
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on today’s hearing in the Massachusetts House Committee on Post Audit and Oversight: “We applaud Massachusetts legislators for examining prescription drug pricing and share the objective of
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released the following statement on the Congressional Budget Office’s (CBO) estimate that The INSULIN Act will increase taxpayer spending by approximately $23 billion over 10 years. Pharmacy benefit managers, PBMs,
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Lower Health Care Costs Act. “While we share the goal of reducing prescription drug costs for consumers, we strongly oppose the legislation,
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on today’s vote in the Commerce Committee on “The Pharmacy Benefit Manager Transparency Act of 2022″ – legislation the industry deems anti-competitive and
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Senate Health, Education, Labor, and Pensions Committee hearing on the Lower Health Care Costs Act: “We commend the Committee for examining important
As independent pharmacies conduct a “Fly-In” in Washington D.C this week, they will undoubtedly double-down on support for policies targeting pharmacy benefit companies that would have profound negative consequences for employers, taxpayers, and patients. It’s important for lawmakers to consider
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the New York Senate Investigations and Government Operations Committee’s report on pharmacy benefit managers (PBMs). “This report attempts to undermine the only industry that is reducing prescription drug
(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on a new report by the U.S. Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE), Office of Health Policy, showing that minorities
©2024 PCMA. All Rights Reserved.
